These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 4290997)

  • 21. The effects of epinephrine, amino acids and albumin on the measurement of insulin by radioimmunoassay.
    Szabo O; Mahler RJ
    Horm Metab Res; 1970 May; 2(3):125-30. PubMed ID: 5535405
    [No Abstract]   [Full Text] [Related]  

  • 22. Clinical aspects of insulin--antigenicity.
    Schlichtkrull J; Brange J; Christiansen AH; Hallund O; Heding LG; Jorgensen KH
    Diabetes; 1972; 21(2 Suppl):649-56. PubMed ID: 5066240
    [No Abstract]   [Full Text] [Related]  

  • 23. Isolation and characterization of soluble insulin-anti-insulin immune complexes formed in vitro and in vivo in sera from patients with diabetes mellitus.
    Kilpatrick JM; Virella G
    Clin Exp Immunol; 1980 Jun; 40(3):445-52. PubMed ID: 6998615
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Different serum insulin patterns in portal, hepatic and peripheral venous blood in two cases of insuloma.
    Erwald R; Hed R; Marions O; Nandorf R; Nygren A; Röjdmark S; Sundblad L; Wiechel KL
    Acta Med Scand; 1972 Mar; 191(3):171-5. PubMed ID: 4338255
    [No Abstract]   [Full Text] [Related]  

  • 25. Elevated circulating proinsulin levels in insulin-requiring diabetic patients.
    Block MB; Mako M; Steiner DF; Rubenstein AH
    J Lab Clin Med; 1971 Nov; 78(5):811-2. PubMed ID: 5316079
    [No Abstract]   [Full Text] [Related]  

  • 26. Circadian variations of carbohydrate tolerance in maturity onset diabetics treated with sulfonylureas.
    Göschke H; Denes A; Girard J; Collard F; Berger W
    Horm Metab Res; 1974 Sep; 6(5):386-91. PubMed ID: 4417576
    [No Abstract]   [Full Text] [Related]  

  • 27. [Immunopathology of diabetes mellitus. Experimental studies on the anti-insulin-serum-diabetes].
    Freytag GH
    Veroff Morphol Pathol; 1972; 88():1-101. PubMed ID: 5022996
    [No Abstract]   [Full Text] [Related]  

  • 28. [Immunologic problems of diabetes mellitus].
    Carta Q; Bumma C; Lanfranco G
    Minerva Med; 1974 Jan; 65(1):60-4. PubMed ID: 4425182
    [No Abstract]   [Full Text] [Related]  

  • 29. Plasma immunoreactive insulin response to 100g-glucose-glucagon-tolbutamide stimulation in juvenile-onset diabetics.
    Takeda R; Usukura N; Miwa U; Nakabayashi H; Kishitani M
    Ala J Med Sci; 1977 Apr; 14(2):125-31. PubMed ID: 855893
    [No Abstract]   [Full Text] [Related]  

  • 30. Heterogeneity of circulating insulin and proinsulin in man.
    Horwitz DL; Rubenstein AH
    Isr J Med Sci; 1974 Oct; 10(10):1201-11. PubMed ID: 4373412
    [No Abstract]   [Full Text] [Related]  

  • 31. [Importance of insulin-antibodies in the complications of the insulin therapy].
    Fankhauser S; Diacon C
    Helv Med Acta Suppl; 1966 May; 46():164. PubMed ID: 4255643
    [No Abstract]   [Full Text] [Related]  

  • 32. Anti-glucagon antibodies in diabetes mellitus.
    Gergely A; Korányl L; Halmos T; Zsombók M; Péterfy F; Csizér F; Salamon F; Takó J
    Ann Immunol Hung; 1973; 17():231-3. PubMed ID: 4808018
    [No Abstract]   [Full Text] [Related]  

  • 33. [Effect of tolbutamide treatment on serum insulin response measured by 3 methods].
    Aburaya K
    Nihon Naibunpi Gakkai Zasshi; 1971 Mar; 46(12):1206-25. PubMed ID: 5102334
    [No Abstract]   [Full Text] [Related]  

  • 34. The circulating proinsulin-like components.
    Gorden P; Roth J; Freychet P; Kahn R
    Diabetes; 1972; 21(2 Suppl):673-7. PubMed ID: 4341002
    [No Abstract]   [Full Text] [Related]  

  • 35. Insulin antibody production studied quantitatively with a modified radioimmunoassay technique and with radioimmunoelectrophoresis in patients treated with monocomponent (MC) insulin.
    Bruni B; Ricci C; Giolitti A; Osenda M; D'Alberto M; Turco GL
    J Nucl Biol Med; 1973; 17(3):123. PubMed ID: 4746315
    [No Abstract]   [Full Text] [Related]  

  • 36. Evaluation of insulin antibodies in insulin treated patients.
    Giampietro O; Giannessi D; Del Chicca MG; Luche AD; Zucchelli GC; Navalesi R
    J Nucl Med Allied Sci; 1980; 24(3-4):153-8. PubMed ID: 7019394
    [No Abstract]   [Full Text] [Related]  

  • 37. Coated charcoal immunoassay of insulin.
    Herbert V; Lau KS; Gottlieb CW; Bleicher SJ
    J Clin Endocrinol Metab; 1965 Oct; 25(10):1375-84. PubMed ID: 5320561
    [No Abstract]   [Full Text] [Related]  

  • 38. Quantitation of free, total, and antibody-bound insulin in insulin-treated diabetics.
    Gennaro WD; Van Norman JD
    Clin Chem; 1975 Jun; 21(7):873-9. PubMed ID: 236845
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of proinsulin on the immunoassay of insulin and its possible relation to states of hyperinsulinemia.
    Lawrence AM; Kirsteins L
    Proc Soc Exp Biol Med; 1969 Sep; 131(4):1142-5. PubMed ID: 4309473
    [No Abstract]   [Full Text] [Related]  

  • 40. A simple method for the determination of serum free insulin levels in insulin-treated patients.
    Nakagawa S; Nakayama H; Sasaki T; Yoshino K; Yu YY
    Diabetes; 1973 Aug; 22(8):590-600. PubMed ID: 4579520
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.